Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Nicox starts Phase ll trial of NCX 470 against latanoprost 0.005%

Conventional surgery to treat glaucoma makes a new opening in the meshwork. Credit: PD.

Go Top